TNGX – tango therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Tango Therapeutics (NASDAQ:TNGX) was given a new $15.00 price target on by analysts at Stifel Nicolaus.
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy [Seeking Alpha]
Tango Therapeutics (NASDAQ:TNGX) had its price target raised by analysts at B. Riley from $8.00 to $14.00. They now have a "buy" rating on the stock.
Form SCHEDULE 13D/A Tango Therapeutics, Inc. Filed by: Third Rock Ventures IV, L.P.
Form 8-K Tango Therapeutics, Inc. For: Nov 18
Form S-3ASR Tango Therapeutics, Inc.
Form S-3 Tango Therapeutics, Inc.
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.